<ARTICLE> 5
<LEGEND>
FINANCIAL DATA SCHEDULE
(Dollars in thousands, except per-share data)
(Unaudited)
</LEGEND>
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                         989,729
<SECURITIES>                                   208,603
<RECEIVABLES>                                1,606,203
<ALLOWANCES>                                    57,019
<INVENTORY>                                    903,369
<CURRENT-ASSETS>                             4,410,255
<PP&E>                                       7,221,292
<DEPRECIATION>                               2,753,690
<TOTAL-ASSETS>                              15,097,238
<CURRENT-LIABILITIES>                        5,653,173
<BONDS>                                      2,102,124
<COMMON>                                       183,005
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   5,790,751
<TOTAL-LIABILITY-AND-EQUITY>                15,097,238
<SALES>                                      3,210,433
<TOTAL-REVENUES>                             3,332,121
<CGS>                                          899,238
<TOTAL-COSTS>                                  971,916
<OTHER-EXPENSES>                             1,340,645<F1>
<LOSS-PROVISION>                                     0<F2>
<INTEREST-EXPENSE>                             138,568
<INCOME-PRETAX>                                964,494
<INCOME-TAX>                                   279,703
<INCOME-CONTINUING>                            684,791
<DISCONTINUED>                                  35,478
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   720,269
<EPS-PRIMARY>                                     2.46
<EPS-DILUTED>                                     2.45
<FN>
<F1>Amounts include research and development, selling and general
and administrative expenses.
<F2>The information called for is not given as the balances are
note individually significant.
</FN>